Steven Wu, MD
Steven Wu, MD
Director of Interventional Nephrology
Medical Director of HD Vascular Access Program
About Steven Wu, MD
Clinical Interests:
- Hemodialysis access management
- Hypertension management
- Renal Artery Stenosis
- Interventional nephrology
- Hemodialysis
- Chronic kidney disease
Treats:
- Adult
Languages:
- Mandarin Chinese
Locations
Renal Associates
165 Cambridge Street
Suite 302
Boston, MA 02114-2752
Phone: 617-726-5050
Medical Education
- MD, Tongji Medical University
- MD, Wuhan Tongji Medical University, China
- Residency, Peking Union Medical College
- Residency, Peking Union Medical College Hospital
- Residency, St. Luke's Hospital
- Residency, St. Lukes's Hospital
- Fellowship, Brigham and Women's Hospital
- Fellowship, Massachusetts General Hospital
American Board Certifications
- Nephrology, American Board of Internal Medicine
- Internal Medicine, American Board of Internal Medicine
Accepted Insurance Plans
- Aetna Health Inc.
- AllWays Health (NHP) - ACD
- AllWays Health (NHP) - PBO
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- BMC HealthNet Mass Health MCO/ACO
- Cigna (PAL #'s)
- Commonwealth Care Alliance
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Maine Community Health Options (MCHO)
- MassHealth
- Medicare
- Medicare - ACD
- OSW - Connecticut
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- Private Health Care Systems (PHCS)
- Senior Whole Health
- TriCare
- Tufts Health Plan
- Unicare
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
Dr. Wu is an Assistant Professor in Medicine at Harvard Medical School. His clinical research is focused on innovative approaches for the diagnosis and treatment of dysfunctional hemodialysis access, peripheral artery diseases, and renal artery stenosis. He currently has several medical innovations related to hemodialysis vascular access interventions being patented and developed at MGH.
#1 Research Hospital in America
Mass General is the #1 Research Hospital in America and the only hospital to be recognized in all 16 specialties assessed by U.S. News & World Report.